146 related articles for article (PubMed ID: 38737285)
1. Identification of methylation driver genes for predicting the prognosis of pancreatic cancer patients based on whole-genome DNA methylation sequencing technology.
Song C; Wang G; Liu M; Xu Z; Liang X; Ding K; Chen Y; Wang W; Lou W; Liu L
Heliyon; 2024 May; 10(9):e29914. PubMed ID: 38737285
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide screening of abberant methylated drivers combined with relative risk loci in bladder cancer.
Zhang C; Shen K; Zheng Y; Qi F; Luo J
Cancer Med; 2020 Jan; 9(2):768-782. PubMed ID: 31794632
[TBL] [Abstract][Full Text] [Related]
3. Identification of epigenetic methylation-driven signature and risk loci associated with survival for colon cancer.
Wang X; Zhang D; Zhang C; Sun Y
Ann Transl Med; 2020 Mar; 8(6):324. PubMed ID: 32355768
[TBL] [Abstract][Full Text] [Related]
4. Identification of methylation-driven genes related to the prognosis of papillary renal cell carcinoma: a study based on The Cancer Genome Atlas.
Liu Z; Wan Y; Yang M; Qi X; Dong Z; Huang J; Xu J
Cancer Cell Int; 2020; 20():235. PubMed ID: 32536823
[TBL] [Abstract][Full Text] [Related]
5. Bioinformatics analysis to screen DNA methylation-driven genes for prognosis of patients with bladder cancer.
Zhou Q; Chen Q; Chen X; Hao L
Transl Androl Urol; 2021 Sep; 10(9):3604-3619. PubMed ID: 34733656
[TBL] [Abstract][Full Text] [Related]
6. Identification and validation of methylation-driven genes prognostic signature for recurrence of laryngeal squamous cell carcinoma by integrated bioinformatics analysis.
Cui J; Wang L; Zhong W; Chen Z; Chen J; Yang H; Liu G
Cancer Cell Int; 2020; 20():472. PubMed ID: 33005105
[TBL] [Abstract][Full Text] [Related]
7. Identification of Prognostic Risk Model Based on DNA Methylation-Driven Genes in Esophageal Adenocarcinoma.
Chen Y; Wang J; Zhou H; Huang Z; Qian L; Shi W
Biomed Res Int; 2021; 2021():6628391. PubMed ID: 34222478
[TBL] [Abstract][Full Text] [Related]
8. Development and Validation of a Novel DNA Methylation-Driven Gene Based Molecular Classification and Predictive Model for Overall Survival and Immunotherapy Response in Patients With Glioblastoma: A Multiomic Analysis.
Wang Z; Gao L; Guo X; Lian W; Deng K; Xing B
Front Cell Dev Biol; 2020; 8():576996. PubMed ID: 33015072
[TBL] [Abstract][Full Text] [Related]
9. Screening of key methylation-driven genes CDO1 in breast cancer based on WGCNA.
Tu S; Zhang H; Qu X
Cancer Biomark; 2022; 34(4):571-582. PubMed ID: 35342080
[TBL] [Abstract][Full Text] [Related]
10. Identification of 4-methylation driven genes based prognostic signature in thyroid cancer: an integrative analysis based on the methylmix algorithm.
Chen Z; Liu X; Liu F; Zhang G; Tu H; Lin W; Lin H
Aging (Albany NY); 2021 Aug; 13(16):20164-20178. PubMed ID: 34456184
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and prognosis potential of four gene promoter hypermethylation in prostate cancer.
Li Y; Meng L; Shi T; Ren J; Deng Q
Cell Biol Int; 2021 Jan; 45(1):117-126. PubMed ID: 32991011
[TBL] [Abstract][Full Text] [Related]
12. Development of a prognostic model for personalized prediction of colon adenocarcinoma (COAD) patient outcomes using methylation-driven genes.
Chen D; Zhang B; Kang K; Li L; Liao Y; Qing S; Di Y
J Appl Genet; 2023 Dec; 64(4):713-721. PubMed ID: 37589877
[TBL] [Abstract][Full Text] [Related]
13. Prognostic biomarker identification and tumor classification in breast cancer patients by methylation and transcriptome analysis.
Zhong X; Zhong G
FEBS Open Bio; 2021 Aug; 11(8):2139-2151. PubMed ID: 34056873
[TBL] [Abstract][Full Text] [Related]
14. Development and Validation of a Prognostic Nomogram for Gastric Cancer Based on DNA Methylation-Driven Differentially Expressed Genes.
Bai Y; Wei C; Zhong Y; Zhang Y; Long J; Huang S; Xie F; Tian Y; Wang X; Zhao H
Int J Biol Sci; 2020; 16(7):1153-1165. PubMed ID: 32174791
[No Abstract] [Full Text] [Related]
15. Identification of methylation-driven genes prognosis signature and immune microenvironment in uterus corpus endometrial cancer.
Liu J; Ji C; Wang Y; Zhang C; Zhu H
Cancer Cell Int; 2021 Jul; 21(1):365. PubMed ID: 34246261
[TBL] [Abstract][Full Text] [Related]
16. Exploring the methylation status of CFTR and PKIA genes as potential biomarkers for lung adenocarcinoma.
Xu B; Zhang J; Chen W; Cai W
Orphanet J Rare Dis; 2023 Aug; 18(1):246. PubMed ID: 37644544
[TBL] [Abstract][Full Text] [Related]
17. Prognostic prediction of a 12-methylation gene-based risk score system on pancreatic adenocarcinoma.
Dou D; Yang S; Zhang J
Oncol Lett; 2020 Jul; 20(1):85-98. PubMed ID: 32565937
[TBL] [Abstract][Full Text] [Related]
18. Identification of DNA methylation-driven genes and construction of a nomogram to predict overall survival in pancreatic cancer.
Deng GC; Sun DC; Zhou Q; Lv Y; Yan H; Han QL; Dai GH
BMC Genomics; 2021 Nov; 22(1):791. PubMed ID: 34732125
[TBL] [Abstract][Full Text] [Related]
19. Identification of key DNA methylation-driven genes in prostate adenocarcinoma: an integrative analysis of TCGA methylation data.
Xu N; Wu YP; Ke ZB; Liang YC; Cai H; Su WT; Tao X; Chen SH; Zheng QS; Wei Y; Xue XY
J Transl Med; 2019 Sep; 17(1):311. PubMed ID: 31533842
[TBL] [Abstract][Full Text] [Related]
20. Development and Validation of Epigenetic Signature Predict Survival for Patients with Laryngeal Squamous Cell Carcinoma.
Cui J; Wang L; Zhong W; Chen Z; Chen J; Yang H; Liu G
DNA Cell Biol; 2021 Feb; 40(2):247-264. PubMed ID: 33481663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]